Shi Y, Zhao Y, Yang S, Zhou J, et al. Safety, Efficacy and Pharmacokinetics of Rezivertinib (BPI-7711) in Advanced Non-Small Cell Lung Cancer Patients with EGFR T790M Mutation: a Phase 1 Dose-Escalation and Dose-Expansion Study. J Thorac Oncol 2022 Feb 15. pii: S1556-0864(22)00084.
PMID: 35181498